PMID- 29462373 OWN - NLM STAT- MEDLINE DCOM- 20190925 LR - 20190925 IS - 1524-4040 (Electronic) IS - 0148-396X (Linking) VI - 83 IP - 6 DP - 2018 Dec 1 TI - The Role of Matrix Metalloproteinase-3 in the Doxycycline Attenuation of Intracranial Venous Hypertension-Induced Angiogenesis. PG - 1317-1327 LID - 10.1093/neuros/nyx633 [doi] AB - BACKGROUND: The molecular mechanism of brain arteriovenous malformation (BAVM) is largely unknown. Intracranial venous hypertension (VH) may enhance focal angiogenesis and promote BAVM development and progression. A rat VH model effectively simulates the hemodynamic microenvironment of this disease. OBJECTIVE: To explore the effect of doxycycline in VH-related angiogenesis, as well as the role of matrix metalloproteinase-3 (MMP-3) and other molecular factors. METHODS: A rat VH model was generated by common carotid artery and distal external jugular vein anastomosis. Microvessel density (MVD) in the perisinus area and expression of MMP-3/2/9, VEGF, TIMP-1, TGF-beta, and HIF-1alpha were examined, with and without daily doxycycline treatment for 4 wk. The effects of doxycycline were verified in Vitro using human brain microvascular endothelial cells (HBMECs). MMP-3 overexpression or knockdown in HBMECs was used to confirm the role of MMP-3 in cell functions. RESULTS: MVD in the perisinus cortex was greatly increased after VH. Doxycycline decreased MVD, suppressed MMP-3 overexpression, and reduced VEGF, TGF-beta, and TIMP-1 levels compared with the controls (P < .05). In Vitro, doxycycline decreased HBMEC migration, tube formation, and the mRNA, protein, and enzymatic activity levels of MMP-3. MMP-3 overexpression in HBMECs promoted migration, while knockdown of MMP-3 significantly attenuated proliferation, migration, and tube formation (P < .05). CONCLUSION: Our findings indicate that MMP-3 plays an important role in VH-related angiogenesis and the promotion of vascular remodeling. Suppression of MMP-3 overexpression by doxycycline may provide a potential strategy for inhibiting BAVM development. FAU - Zou, Xiang AU - Zou X AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Wu, Zehan AU - Wu Z AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Huang, Jun AU - Huang J AD - Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China. AD - The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Liu, Peixi AU - Liu P AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Qin, Xuanfeng AU - Qin X AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Chen, Liang AU - Chen L AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Zhu, Wei AU - Zhu W AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Zhao, Yao AU - Zhao Y AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Li, Peiliang AU - Li P AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Song, Jianping AU - Song J AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Yang, Guo-Yuan AU - Yang GY AD - Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China. FAU - Mao, Ying AU - Mao Y AD - Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. AD - State Key Laboratory of Medical Neurobiology, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China. LA - eng PT - Journal Article PL - United States TA - Neurosurgery JT - Neurosurgery JID - 7802914 RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - N12000U13O (Doxycycline) SB - IM MH - Animals MH - Doxycycline/*pharmacology MH - Humans MH - Intracranial Arteriovenous Malformations/metabolism MH - Intracranial Hypertension/*metabolism MH - Male MH - Matrix Metalloproteinase 3/*metabolism MH - Neovascularization, Pathologic/*metabolism MH - Rats MH - Vascular Remodeling/*drug effects/physiology EDAT- 2018/02/21 06:00 MHDA- 2019/09/26 06:00 CRDT- 2018/02/21 06:00 PHST- 2017/09/09 00:00 [received] PHST- 2017/12/22 00:00 [accepted] PHST- 2018/02/21 06:00 [pubmed] PHST- 2019/09/26 06:00 [medline] PHST- 2018/02/21 06:00 [entrez] AID - 4865224 [pii] AID - 10.1093/neuros/nyx633 [doi] PST - ppublish SO - Neurosurgery. 2018 Dec 1;83(6):1317-1327. doi: 10.1093/neuros/nyx633.